1 / 51

Positioning Nutritional Food Products

Positioning Nutritional Food Products. Sarah E. Taylor, Esq. Covington & Burling Washington, D.C. Positioning Objectives:. Avoid “drug” regulation Optimize health and nutritional claims Optimize nutritional formulation. Position Product to Avoid “Drug” Regulation.

whitley
Télécharger la présentation

Positioning Nutritional Food Products

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Positioning Nutritional Food Products Sarah E. Taylor, Esq. Covington & Burling Washington, D.C.

  2. Positioning Objectives: • Avoid “drug” regulation • Optimize health and nutritional claims • Optimize nutritional formulation

  3. Position Product to Avoid “Drug” Regulation • “Drug” is any article “intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals.”

  4. What is the manufacturer's “intended use “ for the product considering any “relevant source” of information (labeling, advertising, promotions, other)? Does manufacturer state/imply product is intended for use in the diagnosis, cure, migration, treatment, or prevention of disease? Premarket approval of new drug application required. YES “Drug” Flow Chart  1998 Covington & Burling 4

  5. “Drug” Definition: “Intended Use” • Vendor's intent • Determined from any relevant source • labeling • advertising • promotions • “circumstances” surrounding product distribution

  6. Drug Definition: “Disease” • May include — “any deviation from, impairment of, or interruption of the normal structure or function of any part, organ, or system (or combination thereof) of the body that is manifested by a characteristic set of one or more signs or symptoms, including laboratory or clinical measurements that are characteristic of a disease.”

  7. Categories of Prohibited “Disease Claims” • Claims suggesting “the product has an effect on a specific disease or class of disease” • Examples: • “Protective against the development of cancer” • “Reduces the pain and stiffness associated with arthritis” • “Decreases the effects of alcohol intoxication” • “Alleviates constipation”

  8. Claims suggesting that “the product has an effect, using scientific or lay terminology, on . . . signs or symptoms that are recognizable to health care professionals or consumers as being characteristic of specific disease(s).” • Examples: • “Improves urine flow in men over 50 years old” — (characteristic symptom of, e.g., benign prostatic hypertrophy). • “Lowers cholesterol” — (characteristic sign of, e.g., hypercholesterolemia). • “Reduces joint pain” — (characteristic symptom of arthritis). • “Relieves headaches” — (characteristic symptom of, e.g., migraine or tension headache).  1998 Covington & Burling 8

  9. Claims suggesting that a product has an effect on disease through “a statement about the formulation of the product, including a claim that the product contains an ingredient that has been regulated by FDA as a drug and is well known to consumers for its use in preventing or treating disease.” • Examples • “Aspirin” • “Digoxin” • “Laetrile”  1998 Covington & Burling 9

  10. Claims suggesting that a product “belongs to a class of products that is intended to diagnose, mitigate, treat, cure, or prevent a disease.” • Examples • “antibiotic” • “laxative” • “analgesic” • “antiviral” • “vaccine” • “diuretic” • “antimicrobial” • “antiseptic” • “antidepressant” • Permissible S/F Claims • “energizer” • “rejuvenative” • “revitalizer” • “adaptogen”  1998 Covington & Burling 10

  11. Claims suggesting that a product has an effect on disease through the “use of picture, vignettes, symbols, or other means.” • Examples • Electrocardiogram tracings • Pictures of organs that suggest prevention or treatment of a disease state • The prescription symbol (RX) • Any reference to prescription use of the product • Permissible S/F Claims • A picture of the human body  1998 Covington & Burling 11

  12. Claims suggesting that a product “has an effect on a consequence of a natural state that presents a characteristic set of signs or symptoms recognizable to health care professionals or consumers as constituting an abnormality of the body.” • Examples: • “Treats toxemia in pregnancy.” • “For decreased sexual function.” • “For hot flashes.” • “Alzheimer’s disease.” • Permitted S/F Claims: • “For men over 50 years old.” • “To meet nutritional needs during pregnancy.”  1998 Covington & Burling 12

  13. Prohibits claims suggesting that a product has an effect on disease “through the name of the product.” • Examples: • “Carpaltum” (Carpal Tunnel Syndrome). • “Raynaudin” (Raynaud’s Phenomenon). • “Hepatacure” (Liver Problems). • Permitted S/F Claims: • “Cardiohealth” • “Heart Tabs”  1998 Covington & Burling 13

  14. Position Product to Optimize Health and Nutritional Claims • Position product in optimal “nutritional food” category. • Options: • Conventional Food • Food for Special Dietary Use • Dietary Supplement • Medical Food

  15. Conventional “Food:” Definition • Used for “Food” or “Drink” and Components • “Chewing Gum” and Components • “Food” — Consumed for “Taste, Aroma, Nutritive Value.”

  16. Food for Special Dietary Use: Definition • Meets Conventional “Food” Definition • Intended to meet special nutritional needs associated with age, physiological conditions, or disease.

  17. Food for Special Dietary Use: Definition • Distinction from Medical Food: • Useful in supplying special dietary needs for patient prevented from eating normally, BUT • “NOT specifically tailored for use as the nutritional component of the patient’s treatment.”

  18. Food For Special Dietary Use: Definition • Distinction from Medical Food (cont.): • No required “medical supervision” • FDA has attempted to narrow “medical food” category, redefining as foods for special dietary use.

  19. Dietary Supplement: Definition • Labeled as “Dietary Supplement” “Vitamin C Supplement” “Energy Bar Dietary Supplement”

  20. Dietary Supplement: Definition • Intended to supplement the diet and contains a: • vitamin/mineral • herb/botanical • amino acid • dietary substance for use by man to supplement the diet by increasing the total dietary intake, or • concentrate, metabolite, constituent, extract, or combination of the above

  21. Dietary Supplement: Definition • Intended for ingestion in tablet, capsule powder, softgel, or liquid form, OR • Intended for ingestion in another form AND is not represented as a conventional food or the sole item of a meal or the diet

  22. Dietary Supplement: Definition • may not include a food which is “represented for use” as a conventional food, • it may include a food that “simulates” a conventional food.

  23. Dietary Supplement: Definition -- “Simulate" FDA Statement: “. . . there may be dietary supplements for which the presence of the term ‘dietary supplement’ constitutes the primary, if not the only, means by which consumers will be able to determine that the food is a dietary supplement.”

  24. Does manufacturer state/imply product is intended for use in the diagnosis, cure, migration, treatment, or prevention of disease? NO Represented as conventional food or as sole item of meal or diet? Is the product intended to supplement the diet with a dietary ingredient (e.g. herb, botanical, amino acid, or metabolite)? YES NO Dietary Supplement Flow Chart  1998 Covington & Burling 24

  25. Conventional Food: Claims • Approved Nutrient Content Claims • Amount/Percentage Claims • Approved Health Claims • Traditional Structure or Function Claims • Dietary Guidance Claims

  26. Dietary Supplement Claims • Approved Nutrient Content & Health Claims • Amount/Percentage Claims (“40 percent allicin, 10 mg per capsule”) • Dietary Guidance • Traditional Structure or Function Claims (i.e., for DV nutrients only) “Calcium helps build and maintain strong bones.”

  27. Dietary Supplement Claims • “Statements of Nutritional Support” for non-DV dietary ingredients (e.g., herbs): • Disclaimer • 30 Day Postmarket Notice “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”

  28. Third Party Literature -- Dietary Supplements • “Publication” • article • book chapter • official abstract/peer reviewed/appears in article • Reprinted in its Entirety • Not False/Misleading • Promotes No Specific Supplement Manufacturer or Brand • Displayed/Presented With “Other Such Items on Same Subject Matter” to present “balanced view” on supplement • If displayed in an Establishment is Physically Separate from the Dietary Supplements • Has no Information Appended/Attached to it.

  29. Scope of “Nutrient Content Claims” • Definition: “A claim that expressly or implicitly characterizes the level of a nutrient of the type required to be in nutrition labeling” for a food or dietary supplement.

  30. Nutrient Content Claims Must Be Specifically Authorized A nutrient content claim may not be made expressly or impliedly on the label or in labeling unless specifically authorized by FDA regulation (or in limited circumstances by premarket notification).

  31. Scope of “Health Claims” • Definition: “Any claim made . . . in the labeling of food that expressly or impliedly characterizes the relationship of any “substance” to a “disease” or a health-related condition. • Implied health claims may include: • third-party references • brand names • symbols • vignettes.

  32. “Health Claims” Must be Specifically Authorized • A health claim may not be made in labeling unless: • specifically defined by FDA regulation, or • authorized under the premarket notification procedure. • An unapproved health claim = unlawful “drug” claim.

  33. FDA Modernization Act (FDAMA) Claims • FDAMA Authorizes Health and Nutrient Content Claims Based on the Authoritative Statement of a Federal Scientific Body Under a Premarket Notification Procedure. • Premarket Notification Must Be Filed 120 Days Before Claim Introduced to the Market. • FDA Guidance and Interim Final Rules Issued June 1998.

  34. FDAMA Health Claims • FDAMA provides that a health claim “shall be authorized” if “a scientific body of the United States Government with official responsibility for public health protection or research directly relating to human nutrition (such as the National Institutes of Health or the Centers for Disease Control and Prevention) or the National Academy of Sciences or any of its subdivisions has • published an authoritative statement which is currently in effect, • [which is] about the relationship between a nutrient and a disease or health-related condition to which the [health] claim refers.”

  35. FDAMA Health Claims • Premarket Notification • File 120 Days Before First Introduction of Labeled Food. • Exact Words of Claims. • Concise Description of Basis of Claim. • Copy of Authoritative Statement. • Balanced Representation of Scientific Literature.

  36. Dietary Guidance Claims • Key: No reference is made to any specific disease/condition. “The USDA Food Guide Pyramid recommends at least 5 servings of fruits and vegetables daily to reduce the risk of certain chronic diseases.”

  37. “Structure Function” Claims • Conventional “foods” and DV-nutrients: • Claims indicating that the food affects the structure or any function of the body. • E.g., Role of food or nutrient in sustaining normal growth and metabolism. “Calcium helps build and maintain strong bones.”

  38. “Statements of Nutritional Support” (S/F Claims) • Non-DV Dietary Ingredients • Describes role in affecting the structure or function, • Characterizes the mechanism of action, or • Describes benefit to general well-being. “Gingko biloba supports cerebral circulation and alertness.”

  39. Permitted S/F Claims Examples: • “Helps promote urinary tract health” • “Helps maintain cardiovascular function and a healthy circulatory system” • “Helps maintain intestinal flora” • “Promotes relaxation”

  40. Permitted S/F Claims Examples: • “Reduces stress and frustration.” • “Inhibits platelet aggregation.” • “Improves absentmindedness.” • “Helps maintain a healthy cholesterol level.” • “Helps maintain regularity.”

  41. Position Product to Optimize Nutritional Formulation • Considerations: • Dietary Supplements • More Flexible Safety Standards for Dietary Ingredients • May Fortify to Support Claims • Conventional Foods • Food Additive/GRAS Regulation • Standards for Identity • Fortification Policy • Cannot Fortify to Meet Criteria for Certain Claims

  42. Formulation: Conventional “Foods” Fortification Policy: • “Guideline” to Promote “Rational Addition of Nutrients to Food” • Mandatory for “More,” “Healthy,” “High Potency”

  43. Formulation: Conventional “Foods” Fortification Policy: • No fortification of fresh produce, meat, poultry, fish, sugars, snack foods • May correct a “scientifically recognized” dietary insufficiency • May fortify with prescribed nutrient package to “balance”nutrient composition of food

  44. Formulation: Conventional “Foods” Fortification Policy: • May use nutrients for nonnutritional purpose • Must conform with food additive regulations (e.g., folic acid) • Must conform with nutritional criteria for claims • Examine Precedents case-by-case

  45. Formulation: Dietary Supplements • Fortification Policy NA. • Dietary Ingredients Exempt from Food Additive/GRAS Requirements • More Flexible Safety Standards Apply. • Ordinary Food Additive/GRAS Requirements Apply to Excipients, Binders, etc. • FDA has Burden of Proof to Establish Dietary Supplement is Unsafe.

  46. Formulation: Dietary Supplements • A Dietary Ingredient is Prohibited if it: Presents Significant/Unreasonable Risk of Illness/Injury Under Ordinary Conditions of Use OR Causes Dietary Supplement to be Unsafe Under Recommended/Ordinary Conditions of Use

  47. Formulation: Dietary Supplements • A “New Dietary Ingredient” is Prohibited if: • Information Inadequate to Provide “Reasonable Assurance” that there is no Significant/Unreasonable Risk of Illness/Injury Under Ordinary Conditions of Use • “New Dietary Ingredient” First Marketed in the United States On/After October 15, 1994

  48. Formulation: Dietary Supplements • Ingredient in Food Supply • As Article of Food • Not Chemically Altered OR • History of Use/Evidence of Safety Establishing • “reasonably expected to be safe” under recommended conditions of use AND • 75 Day Premarket Notice Filed

  49. FTC Policy Governing Health and Nutritional Claims • The FTC Food Advertising Enforcement Policy Statement interprets and harmonizes FTC's general antideception policies with FDA regulations and policies governing health and nutrition related claims for foods.

  50. FTC Policy: Nutrient Content Claims • Applies FDA's definitions for nutrient content claims (e.g., "low," "high," and "lean"). • Requires synonyms ("packed with" or "lots of") to be used consistently with FDA-defined terms ("high"). • Generally uses FDA's reference amounts as basis for claim. • Consults with FDA and other authorities in evaluating unapproved claims. • Requires the presence of a risk-increasing level of a nutrient to be disclosed.

More Related